Gracell Biotechnologies I... (GRCL)
NASDAQ: GRCL
· Real-Time Price · USD
10.25
0.01 (0.05%)
At close: Feb 21, 2024, 10:00 PM
Gracell Biotechnologies Ratios and Metrics
Financials in CNY. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -1.3 | -0.64 | -0.29 | -0.41 | -0.45 | -0.86 | -0.32 | -0.98 | -2.33 | -2.93 | -3.15 |
PEG Ratio | 0.02 | 0.16 | -0.02 | 0.02 | -0.02 | 0.12 | -0.02 | -0.63 | -0.07 | 0.28 | -0.19 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3.29K | n/a | n/a |
PB Ratio | 0.22 | 0.33 | 0.14 | 0.16 | 0.20 | 0.31 | 0.12 | 0.28 | 0.61 | 0.54 | 0.56 |
P/FCF Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
P/OCF Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.07 | 0.14 | 0.15 | 0.13 | 0.13 | 0.11 | 0.10 | 0.08 | 0.08 | 0.07 | 0.06 |
Quick Ratio | 7.73 | 6.44 | 6.26 | 6.90 | 6.77 | 7.91 | 9.41 | 12.10 | 14.70 | 16.05 | 18.38 |
Current Ratio | 7.73 | 6.44 | 6.26 | 6.78 | 6.77 | 8.01 | 9.41 | 12.15 | 14.70 | 16.05 | 18.38 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.00 | n/a | n/a |
Interest Coverage | -94.38 | -82.84 | -100.6 | -83.37 | -91.09 | -88 | -112.09 | -105.18 | -120.4 | -67.77 | -78.7 |
Return on Equity | -0.04 | -0.13 | -0.13 | -0.09 | -0.11 | -0.09 | -0.09 | -0.07 | -0.07 | -0.05 | -0.04 |
Return on Assets | -0.04 | -0.11 | -0.1 | -0.08 | -0.09 | -0.08 | -0.08 | -0.06 | -0.06 | -0.04 | -0.04 |
Return on Invested Capital | -0.07 | -0.11 | -0.12 | -0.1 | -0.1 | -0.08 | -0.08 | -0.07 | -0.06 | -0.04 | -0.04 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.00 | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -353.24 | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -353.24 | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -358.23 | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -348.07 | n/a | n/a |